Incidentally Detected Ductal Adenocarcinoma Presenting With Isolated Pulmonary Metastasis and a <scp>BRCA2</scp> Mutation

This case illustrates the diagnostic challenges of low-prostate-specific antigen ductal adenocarcinoma and demonstrates the potential of molecular profiling to guide personalized treatment with targeted therapies for rare prostate cancer subtypes.

Authors

Institutions

Publication Details

Journal
IJU Case Reports
Published
2025-11-10
DOI
https://doi.org/10.1002/iju5.70103
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Incidentally Detected Ductal Adenocarcinoma Presenting With Isolated Pulmonary Metastasis and a BRCA2 Mutation

Mototsugu Oya, Akari Komatsuda, Hiroshi Nishihara, Hiroyuki Karasawa et al.
IJU Case Reports
Prostate Cancer Treatment and Research
article

Incidentally Detected Ductal Adenocarcinoma Presenting With Isolated Pulmonary Metastasis and a BRCA2 Mutation

Mototsugu Oya, Akari Komatsuda, Hiroshi Nishihara, Hiroyuki Karasawa, Takeo Kosaka, Yuto Baba, Kohei Nakamura
article en

Abstract

This case illustrates the diagnostic challenges of low-prostate-specific antigen ductal adenocarcinoma and demonstrates the potential of molecular profiling to guide personalized treatment with targeted therapies for rare prostate cancer subtypes.

IJU Case ReportsVol. 9(1)
Keio University (JP), Kawasaki Municipal Hospital (JP)
Openalex Percentile: Top 52%
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.